Reliance Life Sciences Private Limited recalls Pemetrexed for Injection 100mg/Vial
- Recalling company
- Reliance Life Sciences Private Limited
- Product
- Pemetrexed for Injection 100mg/Vial, 1 10 mL Single-Dose Vial per carton, For intravenous use only, Rx only, Manufactured for: Somerset Therapeutics, LLC., Somerset, NJ 08873 NDC: 70069-0834-01
- Reason
- Lack of Sterility Assurance
- Classification
- Class II – may cause temporary or medically reversible health consequences
- Recall date
- Jun 24, 2026
- Reported
- Jul 15, 2026
- Distribution
- Nationwide in the USA
- Status
- Ongoing
- Quantity
- 12,000 vials
- Lot / codes
- Lot, expiry: RPTL0325A Dec 31, 2027; RPTL0425A Dec 31, 2027; RPTL0624B Nov 30,2027; RPTL0625A Mar 31, 2028
- Company location
- Navi Mumbai, N/A
- Recall type
- Voluntary: Firm initiated
- Recall number
- D-0671-2026
- Agency
- U.S. Food and Drug Administration (FDA)
View official FDA notice ↗ Search recall number D-0671-2026 in the FDA Enforcement Report. Also see FDA recall press releases.
If you use this product, check the lot, NDC or model number against the official notice and follow its instructions. Do not stop a prescribed medicine or remove a medical device without talking to your doctor or pharmacist. Report problems to FDA MedWatch. FoodRecallNow summarizes public FDA data and is not medical advice.